Treatment of Schizophrenic Patients With Geodon; Capsules/Oral Suspension/Solution for Injection (Ziprasidone).

Trial Profile

Treatment of Schizophrenic Patients With Geodon; Capsules/Oral Suspension/Solution for Injection (Ziprasidone).

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Sep 2010

At a glance

  • Drugs Ziprasidone (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Acronyms TRITON
  • Sponsors Pfizer
  • Most Recent Events

    • 16 Sep 2010 Last checked against ClinicalTrials.gov record.
    • 19 May 2010 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
    • 19 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top